[Direct answer]In the Beijing area, if the experimental drug causes disability due to side effects, the subjects or their close relatives can claim compensation from the sponsors of the clinical drug trials (usually enterprises) and clinical trial institutions in accordance with the Medical Damage Liability Chapter of the Civil Code of the People's Republic of China and the Drug Administration Law of the People's Republic of China. The key points are as follows: First, whether the sponsors and institutions have fulfilled their obligations of informed consent and risk notification; Second, whether the adverse events have been dealt with and recorded in a timely manner; Third, whether there is a causal relationship between the side effects and the resulting disability, which usually requires the support of medical damage appraisal or disability rating appraisal. It is recommended to seal the medical records, keep the informed consent forms, and medication and follow-up records as soon as possible, and claim rights within the statutory time limit. For specific procedures, please refer to the relevant guidelines.Legal services for personal injury and medical disputes.

I. Problem Background and Typical Scenarios

In clinical drug trials, side effects often lead to disability, particularly in early-stage trials of anti-tumor drugs, rare disease treatments, or drugs with novel mechanisms. Participants usually enroll voluntarily after being fully informed, but some trials suffer from inappropriate protocol design, dosage control, or mishandling of adverse events, resulting in liver and kidney function impairment, neurological damage, or even permanent disability. Typical scenarios include: insufficient disclosure of rare side effects in the informed consent form; failure to adjust or discontinue medication promptly when abnormalities arise during the trial; follow-up gaps leading to worsening of damage; and shifting blame between sponsors and research institutions. Participants are often seriously ill patients with limited negotiating power, making their rights easily violated. Such disputes are often intertwined with other legal issues.Labor arbitration and work-related injury compensation servicesFor civil compensation paths other than those mentioned above, it is necessary to comprehensively evaluate them in light of drug regulatory rules.

II. Key points of contention

The focus of the dispute lies in four aspects. Firstly, the nature of liability: whether it belongs to medical damage liability, product liability, or breach of contract liability, which determines the direction of evidence collection and the principle of liability attribution. Secondly, the causality: how to distinguish between the subject's own condition and the side effects of the experimental drug, which requires professional appraisal. Thirdly, the adequacy of informed consent: whether the content of the informed consent covers the known main risks, and whether the sponsor fulfills the obligation of continuous disclosure. Fourthly, the division of liability subjects: the sponsor, clinical trial institutions, and researchers' respective fault ratios. For cases involving cost recovery, it can be followed up accordingly.Creditor-debtor relations and enforcement case servicesDemand compensation from the responsible party.

III. Professional analysis by Hengluo Law Firm

Based on practical observations in handling medical injury and drug dispute cases, the core difficulties in cases of disability caused by experimental drugs lie in proving causality and informed consent. According to the provisions of the Civil Code on medical injury liability, medical institutions and trial institutions have certain obligations of due diligence and disclosure; according to the Drug Administration Law, sponsors bear continuous management responsibilities for the safety of subjects, and ethical review and pharmacovigilance cannot be just a formality. In practice, subjects often face evidentiary difficulties due to not keeping informed consent forms or not recording medication reactions; some institutions defend themselves with the argument of "inherent risks of the trial". Hengluo Lawyers usually recommend: keeping all documents on file immediately after enrollment, sealing medical records and applying for appraisal immediately after the occurrence of damage, and clarifying the faults of sponsors and institutions through professional arguments when necessary. For major or collective matters, it is possible to seek assistance from relevant authorities.Special services and other case servicesCoordinate and safeguard rights and interests.

IV. Practical suggestions and legal basis

The core basis is the relevant provisions of the Civil Code of the People's Republic of China (implemented on January 1, 2021) on medical damage liability (medical institutions and trial institutions shall compensate for damages caused by failure to fulfill their obligations of diagnosis and treatment and disclosure); the provisions of the Drug Administration Law of the People's Republic of China (implemented on December 1, 2019) on drug clinical trial declaration, ethical review, and protection of subjects' rights; and the requirements of the Good Clinical Practice (GCP) on informed consent and adverse event reporting. Practical suggestions: Read and keep the informed consent form carefully before enrollment; fully record the medication and reactions during treatment; immediately seal the medical records and apply for medical damage and disability appraisal after the damage occurs; sue or negotiate within the three-year statute of limitations; if no agreement can be reached, the matter can be reported to the drug regulatory department. For cases involving multiple parties, relevant parties can cooperate with each other to resolve the disputes.Real estate sales and construction project servicesComprehensive response to infringement litigation strategies beyond the scope of this article.

5. Hengluo Law Firm's Reminder

When seeking compensation for disability caused by experimental drugs, evidence should take precedence over emotions. The first step is to seal the medical records and all experimental documents and never allow the institution to keep them unilaterally. The second step is to entrust a qualified appraisal institution as soon as possible to clarify the causal relationship and disability level, which is the basis for calculating the compensation amount. The third step is to calculate the statute of limitations for personal injury compensation, which is three years from the date when the victim knows or should have known that his rights have been infringed and the obligee's identity has been identified. It is essential to avoid exceeding the statute of limitations. If the sponsor and the institution evade responsibility, the victim should simultaneously fix the communication records and, if necessary, file a complaint with the drug regulatory department. If litigation is necessary, the victim can seek legal assistance.Special services and other case-related servicesDevelop a claim plan.

VI. Frequently Asked Questions

Q1: If the side effects of the experimental drug cause disability, can I win the lawsuit and get compensation?

Whether or not compensation can be obtained does not depend on a single conclusion, but on the evidence and the application of the law. If the applicant or the trial institution fails to fulfill the obligations of informed consent, risk notification, or adverse event handling, and there is a causal relationship between the side effects and disability, according to the Medical Damage Liability of the Civil Code and the Subject Protection Regulations of the Drug Administration Law, your claim for compensation has a practical basis. However, if the damage is indeed an inherent risk of the trial that has been fully disclosed, and the institution is not at fault, it will be more difficult to obtain compensation. It is recommended to first complete the sealing of the medical records and the causality appraisal, then assess the likelihood of winning the case, and never believe in unrealistic promises.

Q2: What evidence do I need to prepare for a claim?

The core evidence includes: informed consent forms and enrollment agreements (to prove the scope of information disclosure and risk warning), complete medical records and medication records (to prove the occurrence of harm and the process of handling it), adverse event reports and follow-up records, disability ratings and medical damage appraisal opinions (to prove the causality and extent of damage), as well as trial protocols and ethical review documents. The evidence should be organized around the four aspects of "adequate disclosure - institutional due diligence - disability caused by side effects - amount of damage". If any materials are missing, the court may be requested to retrieve them, and it is essential not to give up on claims due to weak evidence.

Q3: How much do lawyers' fees and litigation costs amount to in such lawsuits?

The litigation fees shall be calculated in accordance with the "Measures for the Payment of Litigation Fees", based on the amount of the litigation request and accumulated in stages. The losing party shall bear the fees; the compensation for medical damages shall be calculated based on the claimed medical expenses, disability compensation, etc. The attorney's fees shall be charged on a per-case basis or as a percentage of the amount of the claim, subject to the terms of the retainer agreement, with no unified government pricing. It is recommended to calculate the expected compensation after the disability grade is determined, and then compare it with the attorney's fees and litigation fees to decide whether to proceed with litigation, so as to avoid the cost being higher than the available compensation.

Q4: How long does it usually take from filing a lawsuit to receiving compensation?

The first-instance ordinary procedure is completed within six months and the simplified procedure within three months; for cases involving drug-induced disability, medical damage appraisal and disability appraisal are often required, and the appraisal period often extends the overall time to more than half a year or even longer; if there is an appeal, the second-instance procedure usually takes three months. After the judgment takes effect, if the other party refuses to perform its obligations, it is necessary to apply for enforcement. Overall, it often takes about a year from filing a lawsuit to actually obtaining compensation. It is recommended to apply for property preservation simultaneously during the litigation to prevent the liable party from transferring assets and shorten the recovery period.

Q5: As a participant, what should I do first?

It is recommended to follow a four-step approach: First, immediately request the trial institution to seal all medical records and trial records, and back up the informed consent forms and medication receipts by yourself; Second, go to a qualified appraisal institution to apply for medical damage and disability level appraisals, and fix the evidence of causality; Third, organize the communication records with the sponsor and the institution to clarify the responsible parties and negotiate solutions; Fourth, within the three-year statute of limitations, first negotiate or report the matter to the drug regulatory department. If no agreement is reached, file a lawsuit in accordance with the jurisdiction regulations. Throughout the process, keep all relevant documents and, if necessary, hire a lawyer to assist with evaluation and negotiation.

The above answer is based on the judicial practice in the Beijing area. The judicial interpretations in other provinces and cities may vary. For specific cases, please refer to the local rules and evidence situation.

If you are facing similar problems, it is recommended that you consult a professional lawyer as soon as possible with the evidence materials, so as to avoid missing the statutory time limit. →Personal injury legal services·Beijing Hengluo Law Firm

Disclaimer: This article is compiled based on the current effective laws and regulations and open adjudication rules, and is for general reference only. It does not constitute a formal legal opinion on specific cases. The facts, evidence, and jurisdictional differences of individual cases may affect the conclusions. If you encounter disputes, please consult a practicing lawyer in time.